UPDATE: Bionano Genomics costs $200 million underwritten inventory providing at a reduction of $6 a share

Bionano Genomics Inc. priced a $200 million underwritten inventory providing introduced late Tuesday at a reduction of $6 a share, promoting 33.Three million shares. The inventory closed Tuesday at an alltime excessive of $9.14. The genome sequencing firm’s shares have gained 662% within the final 12 months on little information stream, and buying and selling volumes have been lively in current classes. Bionano beforehand bought 29 million shares at $3.05 a share lower than two weeks in the past. The inventory fell 22% in premarket commerce to mirror the dilutive impact of the providing. Oppenheimer was sole bookrunner on the take care of BITG performing as lead supervisor and Ladenburg Thalmann and Maxim Group performing as co-managers. Underwriters have a 30-day choice to buy one other 5 million shares on the providing worth. Bionano shares traded for lower than $1 for a lot of 2020, earlier than costs shot increased simply earlier than the tip of the 12 months regardless of no public bulletins about adjustments on the genome-analysis firm, which misplaced almost $30 million on gross sales of $4.5 million within the first 9 months of 2020.Market Pulse Tales are Speedy-fire, brief information bursts on shares and markets as they transfer. Go to MarketWatch.com for extra info on this information.

Learn Full Story

Newest posts by Market Watch (see all)